Cidara Therapeutics Announces Underwritten Public Offerings of Common Stock and Preferred Stock
SAN DIEGO, March 02, 2023 -- Cidara Therapeutics, Inc. , a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for patients facing serious... | March 2, 2023